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ence of bladder infections despite robust host
defences. Yersiniabactin and aerobactin, two viru-
lence factors related to iron-uptake systems, have
also been associated with relapse [11]; the present
data conﬁrmed these observations, which could be
related to the need of the bacteria to capture iron
for growth in a stressful environment. However,
bioﬁlm productionmay be the key determinant for
the persistence of UPEC in either the vaginal
reservoir, the bladder epithelial cells or both. An
in-vitro bioﬁlm assay could therefore be useful in
clinical practice to select patients who may require
a therapeutic approach directed at erradicating
persistent bioﬁlm-forming E. coli strains in order
to prevent subsequent relapses.
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ABSTRACT
In total, 150 methicillin-resistant Staphylococcus
aureus (MRSA) isolates collected during 2002 from
a general Belgian hospital were phage-typed at
routine test dilution · 100. The majority (45%)
belonged to phage group (J)*, while 10% were
classiﬁed as a new phage type 29 ⁄ (42E) ⁄
54 ⁄ (D11)*. The isolates belonging to this new type
carried the aac(6¢)-aph(2¢¢) and the aph(3¢) amino-
glycoside resistance genes and showed high-level
resistance to oxacillin. Molecular typing revealed
that they belonged to the multiresistant clonal
pulsed-ﬁeld gel electrophoresis (PFGE) type D8.
PFGE group D, characterised as genotype ST228-
MRSA-I, has been present in Belgian hospitals
since 1999.
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Data collected by the European Antimicrobial
Resistance Surveillance System (1999–2002)
showed variable prevalence rates of invasive
methicillin-resistant Staphylococcus aureus (MRSA)
in Europe, with < 1% in Scandinavian hospitals
and > 40% in Mediterranean hospitals. In Bel-
gium, the proportion of MRSA isolated from
patients with S. aureus bacteraemia increased
from 22.1% in 1999 to 27.2% in 2002 [1].
Bacteriophage typing, based on susceptibilities
to an internationally agreed and validated set of
bacteriophages, has been used widely for 50 years
[2]. However, pulsed-ﬁeld gel electrophoresis
(PFGE) of genomic macrorestriction fragments
has now been recognised as a reference standard
for MRSA strain typing, and has been proposed as
a replacement for phage typing [3]. In addition,
DNA sequence-based approaches, such as multi-
locus sequence typing (MLST), are being used
more frequently, as data based on international
MLST nomenclature (http://www.mlst.net) can
easily be exchanged electronically among laborat-
ories. However, MLST is not suitable for local
surveillance or outbreak investigations, and is
used mainly for studies of global epidemiology
and population genetics [4,5].
Gradual changes have been observed in the
phage types of Belgian MRSA isolates during the
last decade. Since 2000, the phage type groups
(O)* and (J)*, found at routine test dilution (RTD)
· 100 (designated by *), have become predomin-
ant [6]. The phage pattern of the (J)* group is
limited to the lytic phages of group III (always
phage 54); in the (O)* group, the phages belong to
group I (phage 80) and group III (always phage
54, never phages 75 ⁄ 85 simultaneously). Molec-
ular analysis has also shown a shift in the PFGE
types found in Belgian hospitals during national
MRSA surveillance studies conducted since 1992
[7–9]. PFGE type A1, which is characterised as
clonal type ST247-MRSA-I by MLST and sta-
phylococcal cassette chromosome mec (SCCmec)
analysis, was predominant in 1992. In contrast,
PFGE types A20 (ST8-MRSA-IV) and B2 (ST45-
MRSA-IV) were recovered more frequently in
2001 [9]. Since 1999, other PFGE groups, e.g., C, D
and G, have been associated with local and
regional outbreaks of infection [8,9]. Changes in
the prevalence of aminoglycoside genes carried
by MRSA strains have also been observed; thus,
the aph(3¢) gene was frequent during the 1980s,
while the aac(6¢)-aph(2¢¢) gene was more prevalent
during the 1990s [9]. A European survey conduc-
ted during 1997 also showed a high prevalence of
aac(6¢)-aph(2¢¢) in MRSA isolates [10], but amino-
glycoside resistance was encoded mainly by
ant(4¢) (40%) and rarely by aac(6¢)-aph(2¢¢) (12%)
or aph(3¢) (5%) in 2001 [9].
In the present study, 150 non-duplicate MRSA
isolates collected from patients hospitalised dur-
ing 2002 at the Jan Yperman Hospital, a 487-bed
general hospital located in northern Belgium,
were phage-typed [2]. The study aimed to mon-
itor the emergence of a new MRSA phage type
29 ⁄ (42E) ⁄ 54 ⁄ (D11)* in that hospital, as well as to
detect its appearance among the isolates received
by the National Phage Typing Centre. Identiﬁca-
tion of MRSA was conﬁrmed by coagulase tests
[11], determination of oxacillin MICs [11] and
detection of the mecA gene by PCR [12]. Phage-
typing experiments found that 25% of isolates
were typable at RTD and 98% at RTD · 100. At
100-fold concentration, 67 (45%) of isolates
belonged to the phage type group (J)*. Of the 83
remaining isolates, 16 (10% of the total) belonged
to the newly recognised phage type
29 ⁄ (42E) ⁄ 54 ⁄ (D11)*. These isolates had an oxacil-
lin MIC >256 mg ⁄L. In contrast, isolates belong-
ing to other phage types had signiﬁcantly lower
oxacillin MICs, in the range of 32)64 mg ⁄L
(p <0.001, Mann–Whitney U-test). During 2002,
the National Phage Typing Centre received 26
other MRSA isolates with high-level oxacillin
resistance belonging to the same phage type
(i.e., 2.5% new phage type ⁄ total isolates). These
isolates were collected from seven other hospitals
located in northern Belgium. A retrospective
analysis of phage type data from 1256 MRSA
isolates collected during 2001 identiﬁed seven
(0.6%) cases with this phenotype, none of which
originated from the Jan Yperman Hospital.
In total, 42 isolates from 2002 that belonged to
this new phage type were examined for amino-
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glycoside resistance (amikacin, gentamicin, net-
ilmicin and tobramycin) by the microdilution
technique according to CLSI recommendations
[13]. PCR analysis of aminoglycoside-modifying
enzymes (AME) genes [12] and PFGE macro-
restriction (SmaI) analysis [7] were also per-
formed. As shown in Table 1, 40 of 42 isolates
harboured a combination of the aac(6¢)-aph(2¢¢)
and aph(3¢) genes, associated with high-level
resistance to gentamicin and tobramycin. The
remaining two isolates carried genes for three
AME enzymes.
The other 134 MRSA isolates collected from the
Jan Yperman Hospital, which belonged to other
phage types, showed lower frequencies of resist-
ance to amikacin, gentamicin, netilmicin and
tobramycin (2.0%, 5.9%, 0% and 55.8%, respect-
ively). The difference was signiﬁcant for gentam-
icin (p <0.001) and tobramycin (p <0.01).
PFGE analysis of the MRSA isolates belonging
to phage type 29 ⁄ (42E) ⁄ 54 ⁄ (D11)* revealed a
single PFGE type, i.e., D8. The PFGE group D
was characterised previously as clonal type
ST228-MRSA-I, and is known to have been epi-
demic in a limited number of Belgian hospitals
since 1999 [8,14,15]. PFGE group D was described
previously as being multiresistant to ciproﬂox-
acin, aminoglycosides and macrolides-lincos-
amides-streptogramins [8]. This genotype has also
been associated with MRSA with reduced sus-
ceptibility to glycopeptides [14,15]. Based on these
results, it seems that continued surveillance of
new epidemic MRSA strains in healthcare settings
can be performed most efﬁciently by using a
combination of a well-standardised phenotypic
typing method and a molecular typing method.
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Table 1. Aminoglycoside resistance characteristics and
pulsed-ﬁeld gel electrophoresis (PFGE) type of phage type
29 ⁄ (42E) ⁄ 54 ⁄ (D11)* isolates of methicillin-resistant Staphy-
lococcus aureus referred to the National Phage Typing







Aminoglycoside resistance (%)a – –
Amikacin 0 (MIC50 8 mg ⁄L) 0 (MIC50 4 mg ⁄L)
Gentamicin 100 (MIC50 128 mg ⁄L) 26 (MIC50 32 mg ⁄L)
Netilmicin 0 (MIC50 4 mg ⁄L) 0 (MIC50 2 mg ⁄L)
Tobramycin 100 (MIC50 32 mg ⁄L) 22 (MIC50 16 mg ⁄L)
AME genes, no. of isolates
aac(6¢)-aph(2¢) + aph(3¢) 14 (87%) 26 (100%)
aac(6¢)-aph(2¢) + aph(3¢) + ant(4¢) 2 (13%) 0
PFGE type D8 D8
aResistance based on CLSI (NCCLS) recommended breakpoints [13].
AME, aminoglycoside-modifying enzyme.
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